Hematology News

The FDA approved fostamatinib disodium hexahydrate for the treatment of adults with chronic immune thrombocytopenia who had insufficient response to a previous treatment.

The FDA expanded the approval of Vonvendi for the treatment of bleeding in adults with von Willebrand disease to include surgical settings, according to the agent’s manufacture.

The FDA granted breakthrough therapy designation to emicizumab-kxwh for the treatment of patients with hemophilia A without factor VIII inhibitors, according to the agent’s manufacturer.

Alexis A. Thompson, MD, MPH, took over as ASH president in January.

Five patients have died while being treated with emicizumab-kxwh for hemophilia A, according to a statement from Hemophilia Federation of America.

Use of red blood cell and plasma transfusions declined across the United States from 2011 through 2014, according to study results.

Although red cell distribution width is a good prognostic indicator for cardiovascular disease and survival, its predictive value is negated among patients who are treated with methotrexate for rheumatoid arthritis, according to findings published in BMC Rheumatology.

Pregnant women with anemia appeared twice as likely to die during or shortly after pregnancy compared with women without anemia, according to an international study.

Patients with lower-limb arterial thrombosis may be susceptible to development of cancer and, subsequently, cancer mortality, according to findings published in Circulation.

SALT LAKE CITY — An altered version of the Hopkins conditioning regimen may lead to more stable donor engraftment without severe toxicity among patients with sickle cell disease who undergo haploidentical hematopoietic stem cell transplantation, according to study data presented at the BMT Tandem Meetings.